07:33 AM EDT, 03/27/2025 (MT Newswires) -- Ascentage Pharma Group ( AAPG ) reported a 2024 loss Thursday of 1.34 renminbi ($0.18) per diluted share, narrower than a loss of 3.28 renminbi a year earlier.

Revenue for the year ended Dec. 31 was 980.7 million renminbi compared with 222 million renminbi a year earlier.

Analyst estimates were not available for comparison.

As of Dec. 31, 2024, cash and bank balances were 1.26 billion renminbi, compared to 1.09 billion renminbi a year earlier.